Journal
CURRENT OPINION IN MICROBIOLOGY
Volume 16, Issue 5, Pages 566-572Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2013.07.010
Keywords
-
Categories
Funding
- CIHR [MOP-84582]
- Genome Canada
- Genome British Columbia
- Vancouver General Hospital AMP
- University of British Columbia Hospital Foundation, through the PRoteomics for Emerging PAthogen REsponse (PREPARE) Project
Ask authors/readers for more resources
Novel classes of antimicrobials are needed to address the challenge of multidrug-resistant bacteria. Current bacterial drug targets mainly consist of specific proteins or subsets of proteins without regard for either how these targets are integrated in cellular networks or how they may interact with host proteins. However, proteins rarely act in isolation, and the majority of biological processes are dependent on interactions with other proteins. Consequently, protein-protein interaction (PPI) networks offer a realm of unexplored potential for next-generation drug targets. In this review, we argue that the architecture of bacterial or host-pathogen protein interactomes can provide invaluable insights for the identification of novel antibacterial drug targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available